MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
33.28
+1.32 (4.13%)
At close: Jun 26, 2026, 4:00 PM EDT
32.61
-0.67 (-2.01%)
After-hours: Jun 26, 2026, 5:02 PM EDT
MapLight Therapeutics Employees
MapLight Therapeutics had 133 employees as of December 31, 2025. The number of employees increased by 70 or 111.11% compared to the previous year.
Employees
133
Change
70
Growth
111.11%
Revenue / Employee
n/a
Profits / Employee
-$1,499,850
Market Cap
1.51B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 133 | 70 | 111.11% |
| Dec 31, 2023 | 63 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Novavax | 749 |
| Immunocore Holdings | 524 |
| Maravai LifeSciences Holdings | 416 |
| Capricor Therapeutics | 231 |
| Maze Therapeutics | 141 |
| MoonLake Immunotherapeutics | 130 |
| ArriVent BioPharma | 77 |
MPLT News
- 3 days ago - MapLight Therapeutics initiated with a Strong Buy at Raymond James - TheFly
- 3 days ago - MapLight Therapeutics Announces Changes to Board of Directors - GlobeNewsWire
- 4 days ago - MapLight Therapeutics price target lowered to $40 from $43 at Craig-Hallum - TheFly
- 5 days ago - MapLight Therapeutics Transcript: Study result - Transcripts
- 5 days ago - MapLight Therapeutics Press release: Study result - Filings
- 5 days ago - MapLight Therapeutics Slides: Study result - Filings
- 5 days ago - MapLight Therapeutics announces IRIS trial misses primary endpoint - TheFly
- 5 days ago - MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder - GlobeNewsWire